Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1.
E David CrawfordAlan H BryceMaha H HussainNeeraj AgarwalHimisha BeltranMatthew R CooperbergDaniel P PetrylakNeal ShoreDaniel E SprattScott T TagawaEmmanuel S AntonarakisAna M AparicioAndrew J ArmstrongThomas P BoikeJeremie CalaisMichael A CarducciBrian F ChapinMichael S CooksonJohn W DavisTanya DorffScott E EggenerFelix Y FengMartin GleaveCelestia HiganoAndrei IagaruAlicia K MorgansMichael MorrisKatie S MurrayWendy PoageMatthew B RettigOliver SartorHoward I ScherPaul SieberEric SmallSandy SrinivasEvan Y YuTian ZhangPhillip J KooPublished in: JU open plus (2024)
CSPC is a diverse disease with many therapeutic options and the potential for adverse outcomes associated with either undertreatment or overtreatment. Future studies are needed to validate and clinically integrate novel technologies, including genomics, AI, and advanced imaging, to optimize outcomes among patients with CSPC.